Literature DB >> 12699370

Use of antibiotic-impregnated cement in total joint arthroplasty.

Thomas N Joseph1, Andrew L Chen, Paul E Di Cesare.   

Abstract

The use of antibiotic-impregnated cement in revision of total hip arthroplasty procedures is widespread, and a substantial body of evidence demonstrates its efficacy in infection prevention and treatment. However, it is not clear that it is necessary or desirable as a routine means of prophylaxis in primary total joint arthroplasty. In the management of infected implant sites, antibiotic-impregnated cement used in one-stage exchange arthroplasties has lowered reinfection rates. In two-stage procedures, use of beads and either articulating or nonarticulating antibiotic-impregnated cement spacers also has lowered reinfection rates. In addition, spacers reduce "dead space," help stabilize the limb, and facilitate reimplantation. Problems associated with antibiotic-impregnated cement in total joint arthroplasty include weakening of the cement and the generation of antibiotic-resistant bacteria in infected implant sites.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12699370     DOI: 10.5435/00124635-200301000-00006

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  36 in total

1.  The results of two-stage revision TKA using Ceftazidime-Vancomycin-impregnated cement articulating spacers in Tsukayama Type II periprosthetic joint infections.

Authors:  Michael Drexler; Tim Dwyer; Paul R T Kuzyk; Yona Kosashvilli; Mansour Abolghasemian; Gilad J Regev; Assaf Kadar; Tal Frenkel Rutenberg; David Backstein
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-08-14       Impact factor: 4.342

2.  [In vitro elution and mechanical properties of antibiotic-loaded SmartSet HV and Palacos R acrylic bone cements].

Authors:  P M S Simpson; G F Dall; S J Breusch; C Heisel
Journal:  Orthopade       Date:  2005-12       Impact factor: 1.087

3.  The antibacterial effects of zinc ion migration from zinc-based glass polyalkenoate cements.

Authors:  D Boyd; H Li; D A Tanner; M R Towler; J G Wall
Journal:  J Mater Sci Mater Med       Date:  2006-06       Impact factor: 3.896

4.  Altering polymerization temperature of antibiotic-laden cement can increase porosity and subsequent antibiotic elution.

Authors:  Jeffrey Sundblad; Mary Nixon; Nancy Jackson; Rahul Vaidya; David Markel
Journal:  Int Orthop       Date:  2018-09-15       Impact factor: 3.075

5.  Chitosan sponges to locally deliver amikacin and vancomycin: a pilot in vitro evaluation.

Authors:  Scott P Noel; Harry S Courtney; Joel D Bumgardner; Warren O Haggard
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

6.  Chitosan films: a potential local drug delivery system for antibiotics.

Authors:  Scott P Noel; Harry Courtney; Joel D Bumgardner; Warren O Haggard
Journal:  Clin Orthop Relat Res       Date:  2008-04-18       Impact factor: 4.176

Review 7.  A clinical review of infected wound treatment with Vacuum Assisted Closure (V.A.C.) therapy: experience and case series.

Authors:  Allen Gabriel; Jaimie Shores; Brent Bernstein; Jean de Leon; Ravi Kamepalli; Tom Wolvos; Mona M Baharestani; Subhas Gupta
Journal:  Int Wound J       Date:  2009-10       Impact factor: 3.315

8.  Prophylactic use of antibiotic-loaded bone cement in primary total knee replacement.

Authors:  Pietro Randelli; Francesco R Evola; Paolo Cabitza; Luca Polli; Matteo Denti; Luca Vaienti
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-10-01       Impact factor: 4.342

Review 9.  Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds.

Authors:  Viviana Mouriño; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2009-10-28       Impact factor: 4.118

10.  Distribution of locally delivered antimicrobials is limited by cortical bone: a pilot study.

Authors:  Ryan Odgers; Keith Jarbo; Alex McLaren; Ryan McLemore
Journal:  Clin Orthop Relat Res       Date:  2013-10       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.